News & Politics
Open Sources Guelph - April 19, 2018
We roll out the red carpet on this week's Open Sources Guelph, and on it is a declaration that this week we're almost all about the Guelph stuff. First up, we'll welcome back Mayor Cam Guthrie for his third appearance on the show, and then we will dig into some discussion on major building projects in the city that have been making a lot of news lately. On top that, we'll talk about the reasons why the ultra rich are terrible this week.
This Thursday, April 19, at 5 pm, Scotty Hertz and Adam A. Donaldson will discuss:
1) The Mayor is In! A lot has happened since the last time we've had Mayor Cam Guthrie in studio, but we'll try and cram as much of it as we can into the first 30 minutes of the show. Likely though, we'll run down a lot of the big items that have been top of mind at city council in the last several weeks, and that means progress on the Baker Street redevelopment, major building projects in the city, the ongoing issues of Guelph Transit, pending service reviews and cuts to the Material Resources Facility, and the update of the taxi bylaw. There's also a local election starting in next week or two, so that might come up too.
2) Development Developments. Speaking of local issues, there's been a lot of buzz around certain Guelph construction projects lately, specifically the proposed 5-storey condo building at 75 Dublin St. N. and the Clair-Maltby secondary plan. On Dublin St, the city is saying no to all five storeys, but the Ontario Municipal Board still has to weigh in on the project. Down in Guelph's deep south meanwhile, residents are disgruntled about the possibility of having 17,000 new neighbours in the last, large stretch of Guelph that's left to be development. We'll recap the highlights and lowlights of the debate.
3) Sick Scams. You ever wonder why modern medicine doesn't cure anything anymore? Well duh, it's because you can't make money off sick people once they've been cured of their disease and the don't need medicine anymore! This cynical evaluation has been brought to you by the good people at Goldman Sachs who put down in writing what we always assumed Big Pharma has thought for years: "Is curing patients a sustainable business model?" analysts asked in an April 10 report entitled "The Genome Revolution." So are Goldman Sach analysts just really horrible people with no ounce of humanity in them? We probably already know the answer.
Open Sources is live on CFRU 93.3 fm and cfru.ca at 5 pm on Thursday.
It is Free